Skip to content
FrontierPicks

Dormant

WK · Workiva Inc.

Last analysed ·

Against its published line

Nothing is through its line on this close.

How to read this

The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on the last session; a dot LEFT of the mark has closed through its line.

Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.

How a pick resolves

WKWorkiva Inc.
$70.00
$76.55
+9.4%well clear

Current thesis

Workiva's earnings re-rating now rests on a higher margin target and paid AI adoption. Q3 delivery against guidance and a weekly close above the 2026-09-04 reference close of $76.55 would confirm the case; a weekly close below $70 invalidates it.

Kill line

A weekly close below $70 ends the recovery thesis; Q3 revenue below the $260 million guidance floor or adjusted operating margin below 17.0% would separately break the operating-delivery premise.

Pick status

Open commitment scored if the kill line above fires How this is scored →

Latest analysis and events for WK —

As of 19 September 2026, the latest FrontierPicks analysis for Workiva Inc. (WK): Workiva's earnings re-rating now rests on a higher margin target and paid AI adoption. Q3 delivery against guidance and a weekly close above the 2026-09-04 reference close of $76.55 would confirm the case; a weekly close below $70 invalidates it.

Kill line: A weekly close below $70 ends the recovery thesis; Q3 revenue below the $260 million guidance floor or adjusted operating margin below 17.0% would separately break the operating-delivery premise.

Current Thesis

Workiva's earnings re-rating now rests on a higher long-term margin target and paid artificial intelligence (AI) adoption; delivery against Q3 guidance and recovery above the September reference close would confirm the case, while a weekly close below $70 invalidates it.

Amplify produced a financial reset: on 2026-09-15, management raised its 2030 adjusted operating-margin target to approximately 26% and reaffirmed its 2030 revenue target of $1.8–2.0 billion. These are management objectives, not achieved results. The earlier concern that the conference might pass without a margin reset therefore did not materialise. Investor Day transcript

The market response remains weaker than the corporate update. The adjusted reference close was $73.18 on 2026-09-18, below $76.55 on 2026-09-04. The inference is that the narrative is maturing — the September conference refreshed the earnings framework without recovering that earlier close; a weekly close above $76.55 accompanied by Q3 delivery would challenge that assessment.

Bullish and bearish views on Workiva Inc.

The model's bull view on Workiva Inc. (WK), in brief: Profitability supports the earnings case. The bear view: Demand still needs confirmation. The 2026-08-04 Q2 results tabulation reported billings growth of 15.2% against revenue growth of 18.6%, with net revenue retention of 111%. Those observations support testing the next quarter for weaker customer expansion; they do not establish a… Both cases follow in full.

Bull Case

  • Profitability supports the earnings case. On 2026-08-04, Workiva reported Q2 revenue of $255.29 million and adjusted earnings per share of $0.77, then guided full-year adjusted earnings per share to $3.38–3.39. Its release identifies approximately 18% as both the 2026 adjusted operating-margin outlook and the prior 2027 target; the previously published description of 16.8% as that target was incorrect. Q2 results
  • Product delivery advances the pivot. Workiva introduced Agent Studio on 2026-09-15, describing tools for building and customising AI agents within governed workflows. The announcement establishes product delivery; it does not by itself establish incremental revenue. Company announcement
  • Pricing provides a monetisation mechanism. At the 2026-09-15 Investor Day, management said advanced AI capabilities sit within premium tiers and described pricing as value-based rather than dependent on user seats. This identifies how adoption can generate revenue, but does not isolate revenue attributable to AI. Investor Day transcript

Bear Case

  • Demand still needs confirmation. The 2026-08-04 Q2 results tabulation reported billings growth of 15.2% against revenue growth of 18.6%, with net revenue retention of 111%. Those observations support testing the next quarter for weaker customer expansion; they do not establish a persistent slowdown from a single quarter.
  • Near-term guidance remains the hurdle. Workiva's 2026-08-04 Q3 outlook called for revenue of $260–262 million and adjusted operating margin of 17.0–17.5%. A subsequent revenue result below $260 million or margin below 17.0% would undermine the operating-delivery case, irrespective of the longer-term target. Q2 results and outlook
  • Analyst support has not restored price. BTIG raised its target from $70 to $80 on 2026-09-11; Stifel maintained its $95 target after Investor Day on 2026-09-17. The 2026-09-18 reference close of $73.18 remained below the 2026-09-04 close of $76.55. These analyst targets are third-party opinions, not evidence of subsequent demand for the shares. BTIG coverage, Stifel coverage

Setup & Price Structure

As of 2026-09-18, the adjusted daily series showed a $73.18 close, a three-month price increase of 59.2%, and a price 21.6% below the $93.31 trailing-year high. The 14-period relative strength index (RSI) was 37.2, compared with 65.1 on 2026-09-04. These are measured price and momentum observations; they do not establish that a base has formed.

The $76.55 close recorded on 2026-09-04 is the recovery reference, and $70 remains the published weekly-close invalidation threshold. Moving-average and volume readings are unavailable, so neither level is presented as a verified moving-average or volume-supported shelf.

Benzinga's 2026-08-31 momentum screen named Workiva as overbought, while the September analyst actions document continuing coverage. That sample is too small to establish retail crowding or expanding institutional participation. The lower RSI on 2026-09-18 describes momentum cooling, not investor positioning.

Catalyst Calendar (next 30 days)

  • 2026-09-20 through 2026-10-20: No company-confirmed catalyst was identified in the reviewed investor calendar. Amplify on 2026-09-14–2026-09-16 and Investor Day on 2026-09-15 have elapsed. The next Q3 results announcement remains the fundamental test, but its publication date was not confirmed; no estimated date is assigned. Workiva investor calendar

What Would Change Our Mind

Loss of the published recovery boundary would end the price thesis: a weekly close below $70 constitutes invalidation. The constructive case would be confirmed by a weekly close above the 2026-09-04 reference close of $76.55 and Q3 results meeting the 2026-08-04 guidance floors of $260 million revenue and 17.0% adjusted operating margin, before that invalidation occurs.

The September margin reset removes the earlier conference-related objection. A Q3 revenue or margin miss would instead break the operating-delivery premise; billings growth below the Q2 rate of 15.2% or net revenue retention below Q2's 111% would provide additional evidence of weakening demand.

Correlation Notes

This remains a single-company earnings and AI-monetisation case. The 2026-09-15 Agent Studio announcement supports an enterprise-software theme, but no measured peer-return correlation or sector-flow series is available as of 2026-09-18. The observed three-month Workiva price increase therefore cannot be attributed to a wider software or AI group move on this evidence.

Notes

  • Dual-class Class A/Class B structure remains in place; Irenic's request to collapse it is unmet as of 2026-09-05.
  • A $238.88M shelf registration for an employee stock offering of Class A shares was filed alongside the Q2 2026 results.
  • Revenue depends on statutory reporting mandates (SEC filing, ESG/sustainability, GRC); management does not break out regime-driven demand.
  • Irenic Capital holds roughly 2% and has publicly requested board seats, annual elections and a strategic review; no settlement announced.
  • Amplify is a customer conference, not a reporting event — the company is under no obligation to disclose a financial metric there.

Related · shared themes

APPN

Appian Corporation

Appian’s AI orchestration re-rating needs Q3 revenue of at least $214 million and cloud subscriptions of at least $133 million to confirm management’s August guidance. A weekly close below $34 or a miss against either revenue floor invalidates the case.

MEDIUM

CRM

Salesforce, Inc.

De-rated Dow software incumbent on two dated legs: the $1.6B VA agentic ELA (2026-07-24) and Reuters' 2026-08-13 report of Silver Lake–Workday take-private talks, which put a private-market floor under mega-cap SaaS. Six target revisions between 2026-08-12 and 2026-08-20 chased price to $209.17; the 2026-08-26 Q2 FY27 print is the binary and much of the discount closed before it.

MEDIUM

CRWD

CrowdStrike Holdings, Inc.

Fal.Con (2026-08-31 to 09-03) delivered real product — Falcon Guardian, Falcon IQ, GPT-5.6 Cyber in Falcon, Anthropic marketplace distribution — and nine broker actions through 2026-09-04 including Truist $300, yet CRWD closed $213.10 on 2026-09-04, below the $218.40 of 08-28 and the $233.88 range high. The catalyst is spent and no company-dated event lands before the ~2026-12-02 Q3 print, leaving a maturing narrative carried by targets rather than a widening bid.

MEDIUM

FROG

JFrog Ltd.

Software-supply-chain-security plus AI-agent "trust layer" narrative keeps re-rating: the analyst cluster now leads price above $100 (UBS Buy $110 Jul 2, Truist Buy $105 Jul 9), confirming the continuation tell flagged in June. Fundamentals accelerating (Q1 rev +26%, security 10% of ARR), but a fresh long is extended near 52-week highs with the ~Aug 6 Q2 print the next binary.

MEDIUM